Founded in 2016, Implant Innovations is a U.S. Food and Drug Administration (FDA) registered and AATB accredited tissue bank focused on producing unique tissue products via a number of distinct allograft processing techniques.
Implant Innovations is involved in the processing, storage and distribution of a number of musculoskeletal allografts including, but not limited to, ProteiOS® and ProGraft™